This week we saw two major deals in the ADC landscape of oncology:   Gilead acquired Immunomedic’s Trop2-directed Trodelvy in a $21B deal, giving the company […]

We were deeply saddened to learn of Chadwick Boseman’s passing after a four year battle with colorectal cancer. Chadwick inspired and entertained millions through his portrayal […]

ACTT Trial Results Indicate Remdesivir’s Efficacy Against Covid-19 The National Institutes of Health released interim #data from the Phase 3 ACTT trial, which explores #remdesivir for […]

#Takeda has added a #Covid19 Expansion arm to their phase 1 trial exploring the small molecule TAK-981 in solid tumors and hematologic malignancies. As this #pandemic […]

#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]

#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]

The COVID-19 WORLDWIDE CLINICAL DEVELOPMENT Dashboard, powered by #Kognitic, is an integrated tool which places the power to deep-dive into #Covid19data in the hands of the […]

Today, #Kognitic released our #Covid_19 dashboard which leverages #machinelearning to capture data from Covid-19 #clinicaltrials in real-time. This portal integrates industry data to provide high-level insights […]

Today, #Kognitic opens public access to our insight-driven, live dashboard to keep abreast of all the #Covid19 clinical developments! Updated daily with data sourced directly from […]